Is a license obtained through the IMLC a full state license?

Yes. A license issued through the compact pathway is a full license from the selected state's medical board. It has that state's renewal schedule, fees, practice rules, and disciplinary oversight. The compact expedites the application and verification process, but it does not create a limited telehealth permit or replace the issuing board's authority.

Does my state belong to the Interstate Medical Licensure Compact?

Check the IMLCC's live state-status page and then the relevant medical board. As of July 31, 2026, 44 states, the District of Columbia, and Guam were members, but Alaska, Arkansas, New Mexico, and Rhode Island were still implementing participation. Membership therefore does not always mean a board is already processing or issuing compact licenses.

Can a physician licensed through the compact prescribe in my state?

A compact-issued license gives the physician the same state authority as a license obtained through the traditional route, subject to that state's prescribing, scope, and telehealth rules. It does not guarantee that any medication is appropriate. A provider must review the individual patient and follow the laws of the state where the patient is located.

Can nurse practitioners use the Interstate Medical Licensure Compact?

No. The IMLC is for eligible physicians. Registered nurses and licensed practical or vocational nurses may be covered by the separate Nurse Licensure Compact. Advanced practice registered nurses, including many nurse practitioners, have a separate APRN Compact, which had four enacted states and was not yet operational as of August 24, 2026.

How long does an IMLC Letter of Qualification last?

A Letter of Qualification is valid for 365 days. During that period, an eligible physician may select additional member states through the IMLCC process by paying the $100 additional-state request fee plus each selected state's license fee. Once the letter expires, the physician must complete the applicable qualification process again to request more licenses.

Does compact membership mean a state is already issuing licenses?

Not necessarily. A state must enact the compact and then complete implementation with its medical board and the IMLCC. As of this review, four member states—Alaska, Arkansas, New Mexico, and Rhode Island—were still implementing. Patients should consult the current IMLCC status page and state board rather than relying only on an enactment date.

Interstate Medical Licensure Compact Guide

The interstate medical licensure compact (IMLC) is a state-law agreement that gives eligible physicians an expedited route to separate, full licenses in participating states. It does not create a national medical license. For a telehealth patient, the practical rule remains simple: the physician must hold a license or other authorization accepted by the state where the patient is physically located during the visit. The compact can make that authorization easier to obtain; it does not replace it.

This is the long-form version of a Promise analysis distributed August 21, 2026 via FinanceWire and carried by Markets Insider.

How the interstate medical licensure compact works

The compact is an agreement enacted by states and administered by the Interstate Medical Licensure Compact Commission (IMLCC). A participating physician begins in a qualifying State of Principal License, or SPL. That state's medical board verifies eligibility and, if the physician qualifies, issues a Letter of Qualification. The physician then selects other compact states and pays their license fees. Each selected board makes the final licensing decision and issues its own license.

That sequence matters. A physician does not receive one portable compact card. The result is a collection of ordinary state licenses reached through a shared, expedited process. A JAMA overview of the compact described that structure as a way to reduce administrative friction in cross-state care while leaving state authority intact.

Current eligibility is narrower than simply holding any medical license. According to the IMLCC's physician guidance, an applicant needs a full, unrestricted license in a member state that can serve as the SPL and must have an eligible connection to that state: primary residence, at least 25% of medical practice, an employer there, or use of the state as the applicant's federal income-tax residence. The physician also must meet education, examination, specialty-certification, background, and disciplinary-history criteria.

The initial IMLCC application fee is $700 and is nonrefundable. State license fees are additional. The Letter of Qualification lasts 365 days; during that window, a physician can request more member-state licenses for a $100 IMLCC fee plus each state's fee. Those are physician-side administrative costs, not a fee charged to a patient for a telehealth visit.

For a patient seeking a tirzepatide consultation, the compact is relevant behind the scenes: it may enlarge the pool of physicians licensed for the patient's location. It never guarantees that a particular clinician, service, or treatment is available.

The growth is visible in both monthly and cumulative data

The compact's scale changed quickly after it became operational. The IMLCC Year 9 data study and the Commission's current dashboard provide a useful timeline.

Date or period	Verified IMLCC measure
April 2017	3 licenses issued in the first operational month
April 1, 2025–March 31, 2026	26,744 licenses issued during Year 9
March 2026	3,633 licenses issued in one month
July 31, 2026	227,966 cumulative licenses issued

The March figure is a monthly count, while 227,966 is a cumulative total; treating them as the same measure would overstate the trend. The IMLCC's August 2026 snapshot also reports 65,558 physician members and 135,772 Letters of Qualification through July 31. One physician can hold multiple state licenses, which is why the license total is much larger than the physician count.

The American Medical Association's June 2026 review adds context for the latest completed compact year: nearly 11,000 physicians applied for Letters of Qualification, applicants obtained an average of four licenses, and 7% were found ineligible. Those figures describe use of the pathway, not patient volume or clinical outcomes.

Cross-state telemedicine is not an edge case limited to people traveling far from home. In a 2022 JAMA Health Forum study, 422,547 traditional Medicare beneficiaries had at least one out-of-state telemedicine visit in the first half of 2021, and 57.2% of those visits involved patients living within 15 miles of a state border. The study reflects temporary pandemic-era policies, so it is context—not an estimate of current compact use.

Where the compact reaches in August 2026

As of July 31, the IMLCC lists 44 member states plus the District of Columbia and Guam, covering 59 licensing boards. But membership and day-to-day operation are not identical. Thirty-eight states, D.C., and Guam can serve as an SPL, process applications, and issue licenses. Hawaii and Vermont issue compact licenses but do not serve as an SPL. Alaska, Arkansas, New Mexico, and Rhode Island are members still implementing participation.

California, Massachusetts, New York, Oregon, South Carolina, and Virginia are the six states outside the compact as of this review. The current IMLCC snapshot notes introduced legislation in Massachusetts and New York, but a pending bill is not membership. Alaska joined on June 26, 2026 as the 44th member state and 46th member jurisdiction; it still appears in the implementation group.

For patients, the safe reading of the map is therefore two-step: is the state a member, and is its board currently issuing compact licenses? The live IMLCC state status and the relevant state medical board are better sources than an older static map. A physician may also hold a state license outside the compact, so absence from the compact does not by itself mean telehealth care is unavailable.

A compact-issued license is still a state license

Every license obtained through the IMLC is a full state license. It renews under that state's rules, carries that state's fees, and places the physician under that medical board's jurisdiction. The IMLCC provides a coordinated application and renewal channel, but it does not set one nationwide scope of practice or standardize every prescribing rule.

The Federation of State Medical Boards' 2022 telemedicine policy says medical practice occurs where the patient is located at the time of the telemedicine encounter and that a physician should be licensed or appropriately authorized there, subject to state exceptions. Our companion analysis on telehealth doctor state licensure explains that patient-location rule in more detail.

This is why a compact license helps without becoming a universal pass. If a patient begins a visit at home and later connects while traveling, the relevant jurisdiction can change. A physician with licenses in both locations may continue care; a physician licensed in only one may need to pause until the patient returns or another lawful route applies. State boards—not the compact's headline membership count—resolve those details.

What patients should verify before a telehealth visit

Start with the place where you will physically sit during the appointment, not your billing address or permanent residence. Confirm that the clinician is licensed or otherwise authorized for that state. Most state medical boards offer a public license lookup showing status and disciplinary information. If a platform cannot explain which state authorization supports the visit, ask before sharing payment or medical details.

Then separate licensure from clinical fit. A current license establishes legal authority; it does not prove that a particular treatment is appropriate for you. That assessment depends on medical history, current medications, contraindications, and the provider's judgment. A sermorelin or semaglutide inquiry follows the same distinction: state authorization opens the door to evaluation, while the evaluation determines what, if anything, may be prescribed. Our overview of telehealth peptide therapy describes that consultation process.

At Promise, a licensed provider reviews every request and not everyone qualifies. The prescribing decision remains between the patient and the reviewing provider. Tirzepatide, sermorelin, and semaglutide programs are available only after the applicable consultation and review; the compact does not change that sequence. See what to expect from your first visit for the patient-side workflow.

The patient-side check still matters after matching

A platform's matching system can reduce friction, but patients should still know the clinician's name and license status. Recheck if you travel, move, or reconnect from another state. Also distinguish the clinician's license from the dispensing pharmacy's license: they are separate regulated roles with separate state requirements. For semaglutide care, as for any telehealth service, compact participation is useful infrastructure rather than a substitute for informed consent, individualized review, and a clear follow-up plan.

Where this analysis was published

This analysis was distributed by FinanceWire on August 21, 2026 and carried by Markets Insider. Promise's related release covers the broader telehealth doctor state licensure rule. Carriage identifies where the release appeared; it does not imply editorial review or endorsement.